Efficacy and safety of the weight-loss drug rimonabant

被引:14
作者
Despres, Jean-Pierre [1 ]
Van Gaal, Luc [2 ]
Pi-Sunyer, Xavier [3 ]
Scheen, Andre [4 ]
机构
[1] Univ Laval, Quebec Heart Inst, Laval Hosp Res Ctr, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Antwerp Hosp, Fac Med, Dept Diabetol Metab & Clin Nutr, Antwerp, Belgium
[3] Columbia Univ, St Lukes Roosevelt Hosp Ctr, New York, NY USA
[4] Univ Liege, Div Diabet Nutr & Metab Disorders, CHU Sart Tilman, Liege, Belgium
关键词
D O I
10.1016/S0140-6736(08)60261-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:555 / 555
页数:1
相关论文
共 3 条
[1]   Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials [J].
Christensen, Robin ;
Kristensen, Pernelle Kruse ;
Bartels, Else Marie ;
Blidda, Henning ;
Astrup, Arne .
LANCET, 2007, 370 (9600) :1706-1713
[2]  
*EUR MED AG, AC SUMM PROD CHAR
[3]   The flawed basis for FDA post-marketing safety decisions: The example of anti-depressants and children [J].
Klein, DF .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (04) :689-699